Brown Advisory’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Brown Advisory’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-23,186	Closed	-$593K	–	1395
2018 Q2	$593K	Buy	23,186 +69	+0.3%	+$1.61K	﹤0.01%	938
2018 Q1	$466K	Buy	+23,117	New	+$539K	﹤0.01%	851
2017 Q1	–	Sell	-522,813	Closed	-$6.59M	–	1204
2016 Q4	$6.59M	Buy	522,813 +20,186	+4%	+$376K	0.02%	336
2016 Q3	$14.1M	Buy	502,627 +39,241	+8%	+$1.32M	0.05%	247
2016 Q2	$16.2M	Buy	463,386 +19,048	+4%	+$599K	0.06%	222
2016 Q1	$12.2M	Buy	444,338 +75,565	+20%	+$2.23M	0.04%	246
2015 Q4	$12.6M	Buy	+368,773	New	+$11.5M	0.04%	242

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Brown Advisory's DPLO Position: Q3 2018 in Review

Brown Advisory sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 23,186 shares — an estimated $593K sold.

Brown Advisory first reported a position in DPLO in Q4 2015 and held it in 7 quarters. The position peaked at $16.2M in Q2 2016. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

Brown Advisory reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
Brown Advisory sold 23,186 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $593K.
Brown Advisory first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 7 quarters.
Brown Advisory's DIPLOMAT PHARMACY, INC. position peaked at $16.2M in Q2 2016.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Brown Advisory's 13F filing for Q3 2018, filed 13 Nov 2018.